Literature DB >> 15639059

Circadian rhythms and arthritis.

Maurizio Cutolo1, Alfonse T Masi.   

Abstract

The clinical symptoms of rheumatoid arthritis (RA) show a circadian variation; joint stiffness and pain are more prominent in the early morning. An altered functioning of the hypothalamic-pituitary-adrenal axis (cortisol) and of the pineal gland (melatonin) seems to be important factors in the perpetuation and clinical circadian symptoms of RA. Consistently, human proinflammatory cytokine production exhibits a diurnal rhythmicity with peak levels during the night and early morning, at a time when plasma cortisol (anti-inflammatory) is lowest and melatonin (proinflammatory) is highest. Sex hormones also seem to be involved in circadian rhythms of RA symptoms. Increased pain intensity and sleep disturbances are observed during the luteal phase in patients who have RA, when estrogen (and progesterone) levels would be higher than in the follicular phase. The occurrence of circadian rhythms of the inflammatory reaction suggest important implications for scheduling activities of daily living, for measurements in clinical trials, and possibly for the time at which antirheumatic drugs--including corticosteroids and nonsteroidal anti-inflammatory drugs--are administered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639059     DOI: 10.1016/j.rdc.2004.09.005

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  21 in total

1.  Serum melatonin level in ankylosing spondylitis: is it increased in active disease?

Authors:  Mohammad Kamal Senna; Shereen Mohamed Olama; Mohammad El-Arman
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

Review 2.  The melatonin-cytokine connection in rheumatoid arthritis.

Authors:  M Cutolo; G J M Maestroni
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

3.  The circadian protein Clock localizes to the sarcomeric Z-disk and is a sensor of myofilament cross-bridge activity in cardiac myocytes.

Authors:  Lixin Qi; Samuel Y Boateng
Journal:  Biochem Biophys Res Commun       Date:  2006-11-07       Impact factor: 3.575

4.  Knee stiffness and viscosity: New implementation and perspectives in prosthesis development.

Authors:  Klemen Bohinc; Nejc Vantur; Drago Torkar; Tomaž Lampe; Marija Hribernik; Miroljub Jakovljević
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

5.  T-cell numbers and antigen-specific T-cell function follow different circadian rhythms.

Authors:  Sarah Kirsch; Stephan Thijssen; Susana Alarcon Salvador; Gunnar H Heine; Kai van Bentum; Danilo Fliser; Martina Sester; Urban Sester
Journal:  J Clin Immunol       Date:  2012-07-15       Impact factor: 8.317

6.  Mathematical modeling of the circadian dynamics of the neuroendocrine-immune network in experimentally induced arthritis.

Authors:  R Rao; D DuBois; R Almon; W J Jusko; I P Androulakis
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-24       Impact factor: 4.310

Review 7.  Air Travel, Circadian Rhythms/Hormones, and Autoimmunity.

Authors:  J Torres-Ruiz; A Sulli; M Cutolo; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

8.  Circadian rest/activity rhythms in knee osteoarthritis with insomnia: a study of osteoarthritis patients and pain-free controls with insomnia or normal sleep.

Authors:  Adam P Spira; Virginia T Runko; Patrick H Finan; Christopher N Kaufmann; Sara C Bounds; Lianqi Liu; Luis F Buenaver; Lea M McCauley; Sonia Ancoli-Israel; Michael T Smith
Journal:  Chronobiol Int       Date:  2014-10-07       Impact factor: 2.877

Review 9.  The Potential of Circadian Realignment in Rheumatoid Arthritis.

Authors:  Rohit T Rao; Kamau K Pierre; Naomi Schlesinger; Ioannis P Androulakis
Journal:  Crit Rev Biomed Eng       Date:  2016

10.  Pathway-level analysis of genome-wide circadian dynamics in diverse tissues in rat and mouse.

Authors:  Alison Acevedo; Panteleimon D Mavroudis; Debra DuBois; Richard R Almon; William J Jusko; Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-03-25       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.